Breast Cancer Treatment Studies
73 researchers across 7 institutions
Researchers investigate novel approaches to combatting breast cancer, focusing on improving therapeutic efficacy and patient outcomes. Studies examine the molecular mechanisms underlying tumor growth and resistance to existing treatments, employing techniques such as genomic analysis, cell culture models, and preclinical testing of new drug candidates. Investigations also explore the role of the immune system in response to cancer and the development of targeted therapies. Methodologies include both laboratory-based experiments and clinical data analysis.
This research holds particular relevance for Arkansas, a state with a significant burden of breast cancer. Understanding treatment effectiveness and identifying disparities in care are critical public health priorities. Work in this area can inform strategies to improve cancer care delivery across the state, potentially impacting the health and well-being of Arkansas citizens. Furthermore, advancements in this field can support the growth of the state's biomedical research sector and contribute to economic development.
This area of study draws upon expertise in pharmacology, molecular biology, immunology, and health outcomes research. Engagement spans multiple institutions across Arkansas, fostering collaboration among faculty, graduate students, and postdoctoral researchers. Connections are also made with research in medical imaging and retrospective health studies.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Laura F. Hutchins | UAMS | 44 | 9,719 | High Impact | |
| Timothy C. Chambers | UAMS | 35 | 4,699 | High Impact | |
| Jawahar L. Mehta | UAMS | 32 | 6,584 | High Impact | |
| Ronda Henry‐Tillman | UAMS | 31 | 3,008 | High Impact | |
| Magda El‐Shenawee | University of Arkansas | 28 | 2,686 | Grant PI High Impact | |
| Jean C. McSweeney | UAMS | 28 | 2,956 | ||
| Behjatolah Monzavi‐Karbassi | UAMS | 24 | 1,617 | Grant PI High Impact | |
| César Sánchez | UAMS | 20 | 2,481 | High Impact | |
| Nawab Ali | UA Little Rock | 19 | 1,693 | Grant PI | |
| Varsha Karunakaran | University of Arkansas | 16 | 807 | ||
| Sayem Miah | UAMS | 15 | 517 | ||
| Fariba Jousheghany | UAMS | 14 | 701 | ||
| Erin M. Taylor | UAMS | 14 | 772 | ||
| Landry K. Kamdem | Harding University Main Campus | 14 | 1,184 | ||
| Julie A. Wallace | UAMS | 14 | 1,828 | ||
| Brandon S.B. Canup | NCTR | 13 | 1,356 | ||
| Laura Adkins | UAMS | 12 | 942 | ||
| Marga F. Massey | University of Arkansas | 11 | 806 | ||
| Daniela Ochoa | UAMS | 9 | 421 | ||
| Pearman D. Parker | UAMS | 9 | 489 |
Related Research Areas
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 The University of Texas MD Anderson Cancer Center 4,726
- 2 Memorial Sloan Kettering Cancer Center 3,494
- 3 Harvard University 2,671
- 4 Dana-Farber Cancer Institute 2,544
- 5 Massachusetts General Hospital 1,583
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Breast Cancer Treatment Studies.